ICD-10-CM Code for Agranulocytosis secondary to cancer chemotherapy D70.1

ICD-10 code D70.1 for Agranulocytosis secondary to cancer chemotherapy is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .

Image 1
Agranulocytosis secondary to cancer chemotherapy
Code also underlying neoplasm
Use additional code for adverse effect, if applicable, to identify drug (T45.1X5)

D70

Includes: agranulocytosis
decreased absolute neurophile count (ANC)

Excludes1: neutropenic splenomegaly (D73.81)
transient neonatal neutropenia (P61.5)

Code also: , if applicable, mucositis (J34.81, K12.3-, K92.81, N76.81)

Use additional code for any associated:
fever (R50.81)

Tabs
Get crucial instructions for accurate ICD-10-CM D70.1 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.
This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code.

Forum

Have a question about ICD-10-CM Code D70.1 ? Start a discussion here